Webinar
Navigating Special Regulatory Pathways for Advanced Therapy Development Success
In this webinar, “Navigating Special Regulatory Pathways for Advanced Therapy Development Success,” our panel of regulatory experts discuss the special regulatory programs designed to accelerate drug development. They share their experiences and insights on navigating pathways such as the RMAT and PRIME designations and other initiatives from the FDA and EMA, which can significantly impact a company’s speed to market and overall success.
Explore how navigating special regulatory pathways can enhance drug development and help lead to improved patient access to innovative therapies.
Speakers:
- Herbert Altmann - VP Market Access & Healthcare Consulting at Cencora
- Christian Schneider - Vice President and Chief Medical Officer at Cencora Pharmalex
- Monica King - Senior Manager, Regulatory Affairs at Cook Myosite
- Nathalie Boeglin - Executive Director, Head of Regulatory Science, Early Stage Programs at Orchard Therapeutics
- Arvind Natarajan - Senior Vice President, Process & Analytical Development at Iovance Biotherapeutics
- Malou Gemeniano - Vice President, CMC Regulatory Affairs at Iovance Biotherapeutics
Fill out the form to watch the session
Pardot Form
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
